Skip to main content
OpenTrials

Clinical trial condition

Mouth Neoplasms

Explore clinical trials studying Mouth Neoplasms. Study availability and eligibility vary by location and protocol.

246 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Mouth Neoplasms trial results

Active, Not Recruiting

Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers

NCT05669664

Conditions
Head and Neck Neoplasms, Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, +9 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT00588770

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
View all 781 locations
View Trial Details
Active, Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

NCT01220583

Conditions
Head and Neck Cancer, Head and Neck Neoplasms, Mouth Diseases, +6 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Arizona Breast Cancer Specialists-Gilbert Gilbert, Arizona, United States
  • Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
View all 268 locations
View Trial Details
Active, Not Recruiting

Amivantamab in Adenoid Cystic Carcinoma

NCT05074940

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Adenoid Cystic, +11 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Rogel Cancer Center - University of Michigan Health Ann Arbor, Michigan, United States
  • Washington University - School of Medicine in St. Louis St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

NCT05237960

Conditions
Erythroplakia, Erythroplasia, Head and Neck Neoplasms, +11 more
Locations
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • UC San Diego Medical Center - Hillcrest San Diego, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
View Trial Details

Related conditions